Sputnik-v Vaccine

Russia's Sputnik-V vaccine and its one-shot version Sputnik Light booster demonstrates high virus-neutralising activity (VNA) against the Omicron variant of COVID-19, providing a strong defence against hospitalisation, according to a study.

Russia has said that it hopes that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it was recommended for use in India by a committee of experts.

Russia's Covid vaccine Sputnik V has been recommended for use in India by a committee of experts as the country battles a record spike in infections.

Russia's Covid vaccine Sputnik-V has been cleared for emergency use approval in India by a committee of experts in the middle of a record spike in virus cases in the country.

Russian journalists working for two state-owned media outlets are among the first to be offered the new Sputnik V COVID-19 vaccine outside of the framework of a clinical trial, according to one of the outlets and four employees.

India reported its lowest daily tally of coronavirus cases in almost a month on Tuesday as it prepares for clinical trials of a potential Russian vaccine in the next few weeks.

Dr Reddy's Laboratories Ltd could begin late-stage clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the drugmaker said.

Russia's sovereign wealth fund has said it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against COVID-19 once it receives regulatory approval in the country.

Twenty-six scientists, most of them working at universities in Italy, have signed an open letter questioning the reliability of the data presented in the early-stage trial results of the Russian COVID-19 vaccine, named "Sputnik-V".

India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" COVID-19 vaccine, with several Indian companies currently studying the proposal, a government official said on Tuesday.

Russia's plan to roll-out its "Sputnik-V" COVID-19 vaccine even before full trials show how well it works is prompting concern among virus experts, who warn a partially effective shot may encourage the novel coronavirus to mutate.

Russia's Sputnik-V vaccine and its one-shot version Sputnik Light booster demonstrates high virus-neutralising activity (VNA) against the Omicron variant of COVID-19, providing a strong defence against hospitalisation, according to a study.

Russia has said that it hopes that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it was recommended for use in India by a committee of experts.

Russia's Covid vaccine Sputnik V has been recommended for use in India by a committee of experts as the country battles a record spike in infections.

Russia's Covid vaccine Sputnik-V has been cleared for emergency use approval in India by a committee of experts in the middle of a record spike in virus cases in the country.

Russian journalists working for two state-owned media outlets are among the first to be offered the new Sputnik V COVID-19 vaccine outside of the framework of a clinical trial, according to one of the outlets and four employees.

India reported its lowest daily tally of coronavirus cases in almost a month on Tuesday as it prepares for clinical trials of a potential Russian vaccine in the next few weeks.

Dr Reddy's Laboratories Ltd could begin late-stage clinical trials of Russia's potential coronavirus vaccine in the next few weeks, an executive at the drugmaker said.

Russia's sovereign wealth fund has said it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against COVID-19 once it receives regulatory approval in the country.

Twenty-six scientists, most of them working at universities in Italy, have signed an open letter questioning the reliability of the data presented in the early-stage trial results of the Russian COVID-19 vaccine, named "Sputnik-V".

India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" COVID-19 vaccine, with several Indian companies currently studying the proposal, a government official said on Tuesday.

Russia's plan to roll-out its "Sputnik-V" COVID-19 vaccine even before full trials show how well it works is prompting concern among virus experts, who warn a partially effective shot may encourage the novel coronavirus to mutate.